Alcami Corp., a provider of custom development and manufacturing services for the pharma and biopharma industries, has opened its international sales office in Tokyo, Japan. The company is expanding its presence in Japan and the new branch will provide a home base for Alcami’s local customers and serve Japanese companies interested in developing and manufacturing products for launch in the U.S.
 
“The establishment of dedicated offices in Tokyo further advances Alcami’s mission to deliver exceptional individualized client services around the world,” said Dr. Stephan Kutzer, chief executive officer, president and chairman of Alcami Corp. “We see strong potential for development in the Japanese region and are confident this expansion will enable us to better service our Japanese customers to launch their products in the U.S. market.”

The new office, located in the Shiodome business center in Tokyo, opened last week with a ribbon cutting ceremony attended by local partners, customers, and Alcami executives and commercial leaders, Catherine Hanley, senior director of marketing and corporate communications, and Syed T. Husain, chief commercial officer.

The office space will initially house representatives of Alcami’s global sales and business development team, with plans to later include quality, regulatory, and project management teams.